Semaglutide is a GLP-1 receptor agonist that is commonly known by the brand names Wegovy for weight loss and Ozempic for type 2 diabetes. Semaglutide is taken as a weekly subcutaneous injection.
Tirzepatide is a GLP-1 receptor agonist and GIP (glucose-dependent insulinotropic polypeptide) receptor. It is commonly known by the brand names Mounjaro for type 2 diabetes and Zepbound for weight loss.